About: Noriyuki Satō

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Noriyuki Satō Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Japanese medical researcher

Attributes	Values
rdf:type	Item
description	Japanese medical researcher (en) investigador médicu xaponés (ast)
rdfs:label	Noriyuki Satō (en) Noriyuki Satō (tr) Noriyuki Sato (ast) 佐藤昇志 (ja)
skos:prefLabel	Noriyuki Satō (en) Noriyuki Satō (tr) Noriyuki Sato (ast) 佐藤昇志 (ja)
name	Noriyuki Satō (en) Noriyuki Satō (tr) Noriyuki Sato (ast) 佐藤昇志 (ja)
given name	wds:Q113953738-fc4450d7-4860-895c-15fe-bb94a7fb0105
given name	Noriyuki
instance of	wds:Q113953738-bfbfea2a-4633-a68f-e581-5244047714f0
instance of	Homo sapiens
Researchmap ID	wds:Q113953738-8c5ed66f-4258-5460-6dec-3c143a87a605
Researchmap ID	read0064662
skos:altLabel	Noriyuki Sato (en) Noriyuki Satou (en) Sato Noriyuki (en) Satou Noriyuki (en) Satō Noriyuki (en)
occupation	wds:Q113953738-c9c9c055-44e1-a46b-6f2f-406d670c6d4d
employer	wds:Q113953738-3897401a-4d2f-ab13-ce1b-430432d12cf7
CiNii Research ID	wds:Q113953738-3F4FF8A9-4522-4143-ABCC-52454A09A0DB
name in native language	wds:Q113953738-19915272-4a6b-2560-9545-7529d72611c9
sex or gender	wds:Q113953738-b8955ce1-4124-d155-31cf-f9e961c20ed2
country of citizenship	wds:Q113953738-f59e55d0-4219-be38-676b-b0d242fdd20d
family name	wds:Q113953738-37283794-43d0-bede-d9a4-28b9eb01c393
J-GLOBAL ID	wds:Q113953738-a7f34088-4046-d8f6-ab3f-cf1f2dff08c5
CiNii Research ID	https://cir.nii.ac.jp/crid/1420564276185753216.rdf
occupation	medical researcher
employer	Sapporo Medical University
CiNii Research ID	1420564276185753216
name in native language	佐藤昇志 (ja)
sex or gender	male
country of citizenship	Japan
family name	Satō
J-GLOBAL ID	200901044107159229
e-Rad researcher number	wds:Q113953738-5a55d1b5-4950-d8d1-4d90-57138fb62479
e-Rad researcher number	50158937
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q113953738
is author of	Effects of inhaled FK 506 on the suppression of acute rejection after lung transplantation: use of a rat orthotopic lung transplantation model Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells. Histone deacetylation, but not hypermethylation, modifies class II transactivator and MHC class II gene expression in squamous cell carcinomas Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor A gene encoding human gastric signet ring cell carcinoma antigen recognized by HLA-A31-restricted cytotoxic T lymphocytes SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer. Detection of anti-livin antibody in gastrointestinal cancer patients. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients Towards the introduction of the 'Immunoscore' in the classification of malignant tumours Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma The functioning antigens: beyond just as the immunological targets Anti-tumor effect of orally administered spinach glycolipid fraction on implanted cancer cells, colon-26, in mice Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5 Wild-type AIRE cooperates with p63 in HLA class II expression of medullary thymic stromal cells Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells Resveratrol inhibits fibrogenesis and induces apoptosis in keloid fibroblasts Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal Cancer classification using the Immunoscore: a worldwide task force ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Heat-shock proteins as endogenous ligands building a bridge between innate and adaptive immunity Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute Improved generation of HLA class I/peptide tetramers Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma. Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma Circulating interleukin-18 and osteopontin are useful to evaluate disease activity in patients with tuberculosis N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line An immunosuppressive effect by synthetic sulfonolipids deduced from sulfonoquinovosyl diacylglycerols of sea urchin Sorting nexin 5 of a new diagnostic marker of papillary thyroid carcinoma regulates Caspase-2 Potential survival benefit of anti-apoptosis protein: survivin-derived peptide vaccine with and without interferon alpha therapy for patients with advanced or recurrent urothelial cancer--results from phase I clinical trials SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis Extracellular heat shock protein 90 plays a role in translocating chaperoned antigen from endosome to proteasome for generating antigenic peptide to be cross-presented by dendritic cells Tumor-produced secreted form of binding of immunoglobulin protein elicits antigen-specific tumor immunity Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma Detection of autoantibodies to survivin and livin in sera from patients with breast cancer Molecular pathological approaches to human tumor immunology

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software